CCBIO Opinions through the years
2022
- The Promise of Patient Selection in Targeting the Tumor Microenvironment, by Rolf Brekken
- How to Efficiently Organize Translational Cancer Research? By Frédéric Amant
- Living with Ovarian Cancer: Transitions Lost in Translation, by Karen Rosnes Gissum, Line Bjørge, and Roger Strand
- Promises and Problems of Precision Oncology, by Line Bjørge
2021
2020
- Challenges in Contemporary Precision Medicine, by Agnete Engelsen, Bjørn Tore Gjertsen, and James Lorens
- Evaluating Personalized Cancer Drugs, by Eirik Joakim Tranvåg
- Challenges in Breast Cancer Prevention, by Mark LaBarge
- CCBIO on Career Development, by Yamila Torres Cleuren
2019
- Transformative Forces in Translational Cancer Research, by Ian Mills
- "Good Enough" Biomarkers in a Centre of Excellence? By Anne Bremer and Elisabeth Wik
- Cancer in the News, by Mille S Stenmarck and Irmelin W. Nilsen
- South African Diamond Miners One Hundred Years Ago and Laboratory Researchers (or Biologists) Today, by Marta Bertolaso
2018
- Too Much Data? The Gastro Perspective. By Roger Strand and Inge Jonassen
- The Tumor Microenvironment: Barrier or Support? By Donald Gullberg and Arne Östman
- p53 Isoforms: Guardians of the Tumor–Host Interaction. By Jean-Christophe Bourdon and Bjørn Tore Gjertsen
- Precision Medicine: Lost in Translation? By Caroline Engen
- Integration of Innovation. By Yves Aubert
2017
- Prospects of Next Generation Tissue Profiling. By Lars A. Akslen
- Precision Fairness? By John Cairns, Ole F. Norheim, and Roger Strand
- Precision Medicine: Fairness and the Big Pharma Perspective. By Hani Gabra
2016
- Repurposing Drugs for Cancer Therapy. By Bjørn Tore Gjertsen and Karl-Henning Kalland
- Prioritization. By Eirik Tranvåg and Ole Frithjof Norheim
- What is Responsible Cancer Research? By Roger Strand and Lars A. Akslen
- The Decathlon of the Young Researcher. By Jean Paul Thiery
2015
- CCBIO on the Tumor Microenvironment. By James B. Lorens
- CCBIO on Targeted Treatment. By Bjørn Tore Gjertsen
- CCBIO on Ethics. By Anne Blanchard
2014
- Health Priorities should be Open, Just, and Smart. By Roger Strand
- The Economics of Cancer Biomarkers. By John Cairns